My ePortfolio Register   

Inequalities in immuno-oncology access across Europe

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.12.17
Views: 920

Dr Lydia Makaroff - European Cancer Patient Coalition, Brussels, Belgium

Lydia Makaroff talks to ecancer at EAPM 2017 in Belfast.

She spoke about the importance of innovation in immuno-oncology therapy in cancer.

She underlines the inequalities across Europe to access to these therapies.

This could be due to inefficiencies, lack of cooperation, and lack of healthcare literacy.

She believes patients should be at the centre of care and treatment.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence